Login Register Cart 0
Generic placeholder image

Infectious Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

The Relationship Between HIV Antibody Titer, HIV Viral Load, HIV p24 Antigen, and CD4 T-cell Count Among Iranian HIV-positive Patients

Author(s): Majedeh Moradbeigi, SeyedAhmad SeyedAlinaghi, Mansour Sajadipour, Omid Dadras, Esfandiar Shojaei, Parisa Ahmadi, Saeed Bayanolhagh, Kazem Baesi* and Mehrnaz Rasoolinejad*

Volume 20, Issue 5, 2020

Page: [752 - 757] Pages: 6

DOI: 10.2174/1871526519666191104144721

Price: $65

Abstract

Objective: This study aimed to simultaneously measure and assess the correlation between the available HIV infection parameters including HIV antibody, p24 Antigen, CD4 cell count, and viral load at the different stages of HIV disease among HIV-positive individuals in Iran.

Materials and Methods: Fifty HIV-positive individuals were classified into three stages (1, 2, and 3) according to the HIV disease stages classification, available in Control of Disease and Prevention (CDC) guideline. 10 ml of the venous blood sample was collected to run the tests for HIV antibody and p24 Ag levels, CD4 cell counts, and viral load. Pearson’s correlation test was employed to calculate the coefficients for the in-between correlation of different HIV parameters in each stage.

Results: Of 50 participants, 17 (34%), 25 (50%), and 8 (16%) patients belonged to stages 1, 2, and 3, respectively. Sexual relationship was the main route of HIV transmission among the patients (36%); however, injecting drug use (20%) was also reported frequently. There was no significant correlation between the parameters of HIV disease in different stages in the present study.

Conclusion: The findings showed no correlation between HIV parameters in the present study. Considering the fact that the association of HIV antibodies with HIV disease progression in infected individuals is independent of HIV-1 RNA levels, combined measurement of HIV-1 RNA and CD4 cell counts should be routinely carried out in HIV infected patients follow up.

Keywords: P24 Ag, HIV viral load, CD4 count, HIV antibody, correlation, HIV-1 RNA.

[1]
UNAIDS. Fact sheet – global AIDS update. , 2019. Available from https://www.unaids.org/en/resources/fact-sheet
[2]
KFF/UNAIDS. The Global HIV/AIDS Epidemic; , 2019. Available from https://www.kff.org/global-health-policy/fact-sheet/the-global-hivaids-epidemic/
[3]
Bradley, H.; Hall, H.I.; Wolitski, R.J.; Van Handel, M.M.; Stone, A.E.; LaFlam, M.; Skarbinski, J.; Higa, D.H.; Prejean, J.; Frazier, E.L.; Patel, R.; Huang, P.; An, Q.; Song, R.; Tang, T.; Valleroy, L.A. Vital Signs: HIV diagnosis, care, and treatment among persons living with HIV--United States, 2011. MMWR Morb. Mortal. Wkly. Rep., 2014, 63(47), 1113-1117.
[PMID: 25426654]
[4]
Sajadi, MM; Guan, Y; DeVico, AL; Seaman, MS; Hossain, M; Lewis, GK Correlation between circulating HIV-1 RNA and broad HIV-1 neutralizing antibody activity. Journal of acquired immune deficiency syndromes (1999);; , 2011, 57, p. (1)9.
[5]
Hunt, P.W.; Brenchley, J.; Sinclair, E.; McCune, J.M.; Roland, M.; Page-Shafer, K.; Hsue, P.; Emu, B.; Krone, M.; Lampiris, H.; Douek, D.; Martin, J.N.; Deeks, S.G. Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J. Infect. Dis., 2008, 197(1), 126-133.
[http://dx.doi.org/10.1086/524143] [PMID: 18171295]
[6]
Winters, M.A.; Tan, L.B.; Katzenstein, D.A.; Merigan, T.C. Biological variation and quality control of plasma human immunodeficiency virus type 1 RNA quantitation by reverse transcriptase polymerase chain reaction. J. Clin. Microbiol., 1993, 31(11), 2960-2966.
[PMID: 7903317]
[7]
Lin, H.J.; Haywood, M.; Hollinger, F.B. Application of a commercial kit for detection of PCR products to quantification of human immunodeficiency virus type 1 RNA and proviral DNA. J. Clin. Microbiol., 1996, 34(2), 329-333.
[PMID: 8789009]
[8]
Van Kerckhoven, I.; Fransen, K.; Peeters, M.; De Beenhouwer, H.; Piot, P.; van der Groen, G. Quantification of human immunodeficiency virus in plasma by RNA PCR, viral culture, and p24 antigen detection. J. Clin. Microbiol., 1994, 32(7), 1669-1673.
[PMID: 7929756]
[9]
Coste, J.; Montes, B.; Reynes, J.; Peeters, M.; Segarra, C.; Vendrell, J.P.; Delaporte, E.; Segondy, M. Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma. J. Med. Virol. 1996, 50(4), 293-302.
[http://dx.doi.org/10.1002/(SICI)1096-9071(199612)50:4<293::AID-JMV3>3.0.CO;2-3] [PMID: 8950685]
[10]
Vincent, F.; Raynal, N.; Francois, A.; Belec, L.; Duboust, A.; Glotz, D., Eds.; False-positive p24 antigenaemia detected in renal allograft recipients: possible role of rabbit antithymocyte globulins; , 1995.
[11]
O’Brien, W.A.; Hartigan, P.M.; Daar, E.S.; Simberkoff, M.S.; Hamilton, J.D. Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. Ann. Intern. Med., 1997, 126(12), 939-945.
[http://dx.doi.org/10.7326/0003-4819-126-12-199706150-00002] [PMID: 9182470]
[12]
Ho, D.D. Viral counts count in HIV infection. Science, 1996, 272(5265), 1124-1125.
[http://dx.doi.org/10.1126/science.272.5265.1124] [PMID: 8638155]
[13]
Coombs, R.W.; Welles, S.L.; Hooper, C.; Reichelderfer, P.S.; D’Aquila, R.T.; Japour, A.J.; Johnson, V.A.; Kuritzkes, D.R.; Richman, D.D.; Kwok, S.; Todd, J.; Jackson, J.B.; DeGruttola, V.; Crumpacker, C.S.; Kahn, J. Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. AIDS Clinical Trials Group (ACTG) 116B/117 Study Team. ACTG Virology Committee Resistance and HIV-1 RNA Working Groups. J. Infect. Dis., 1996, 174(4), 704-712.
[http://dx.doi.org/10.1093/infdis/174.4.704] [PMID: 8843206]
[14]
Mellors, J.W.; Muñoz, A.; Giorgi, J.V.; Margolick, J.B.; Tassoni, C.J.; Gupta, P.; Kingsley, L.A.; Todd, J.A.; Saah, A.J.; Detels, R.; Phair, J.P.; Rinaldo, C.R. Jr Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann. Intern. Med., 1997, 126(12), 946-954.
[http://dx.doi.org/10.7326/0003-4819-126-12-199706150-00003] [PMID: 9182471]
[15]
Mohraz, M.; Tayeri, K.; Namdari Tabar, H.; Bayat Jozani, Z.; Sadeghi, L. SeyedAlinaghi S, Esmaeilzadeh A, Adl Tabatabai R, Sajjadipour M, Gholami M, Bayanolhagh S. Evaluation of Acquired HIV Drug Resistance among People Living with HIV Who Have Taken Antiretroviral Therapy for 9-15 Months in 14 Triangular Clinics in Iran, 2015-2016. Intervirology, 2018, 61(6), 292-300.
[http://dx.doi.org/10.1159/000497036]]
[16]
Ghodrati, S.; Shahabinezhad, Z. SeyedAlinaghi S. Association Between Immunologic and Virologic Functioning and Health-Related Quality of Life Among People Living with HIV, Tehran, Iran. Infect. Disord. Drug Targets, 2019, 19(3), 297-303.
[17]
Firouzeh, MM.; Moradbeigi, M. SeyedAlinaghi SA, Khodaei S, Sadrpour P, Bayanolhagh S, Ahsani-Nasab S, Sadeghi L, Mohraz M. Demographic, Clinical and Laboratory Profiles of HIV Infected Patients Admitted into Imam Khomeini Hospital of Tehran, Iran. Infect. Disord. Drug Targets, 2016, 16(2), 113-120.

Rights & Permissions Print Cite
Article Metrics
42
© 2024 Bentham Science Publishers | Privacy Policy